Ritu Baral
Stock Analyst at TD Cowen
(3.80)
# 748
Out of 5,124 analysts
45
Total ratings
52.63%
Success rate
10.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Initiates: Buy | $67 | $42.69 | +56.95% | 1 | Jan 5, 2026 | |
| INSM Insmed | Maintains: Buy | $269 → $241 | $174.99 | +37.72% | 7 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $97 → $133 | $97.23 | +36.79% | 3 | Dec 16, 2025 | |
| MIST Milestone Pharmaceuticals | Upgrades: Buy | $8 | $2.16 | +270.37% | 1 | Dec 15, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $251 → $353 | $290.34 | +21.58% | 1 | Dec 8, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $60 → $73 | $48.49 | +50.55% | 2 | Dec 5, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $78 → $74 | $72.28 | +2.39% | 2 | Oct 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $35 → $39 | $27.27 | +43.01% | 2 | Sep 11, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $390 → $554 | $561.44 | -1.33% | 2 | Aug 26, 2025 | |
| SPRO Spero Therapeutics | Downgrades: Hold | n/a | $2.60 | - | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.10 | - | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $282 → $371 | $421.74 | -12.03% | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.55 | - | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $175 | $22.60 | +674.34% | 1 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $82.01 | - | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $0.70 | - | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $17.15 | - | 1 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.97 | - | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $38.53 | - | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.33 | - | 1 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.55 | - | 2 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $619.43 | - | 2 | Jan 12, 2018 |
vTv Therapeutics
Jan 5, 2026
Initiates: Buy
Price Target: $67
Current: $42.69
Upside: +56.95%
Insmed
Dec 18, 2025
Maintains: Buy
Price Target: $269 → $241
Current: $174.99
Upside: +37.72%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $97 → $133
Current: $97.23
Upside: +36.79%
Milestone Pharmaceuticals
Dec 15, 2025
Upgrades: Buy
Price Target: $8
Current: $2.16
Upside: +270.37%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $251 → $353
Current: $290.34
Upside: +21.58%
Vera Therapeutics
Dec 5, 2025
Maintains: Buy
Price Target: $60 → $73
Current: $48.49
Upside: +50.55%
Avidity Biosciences
Oct 29, 2025
Downgrades: Hold
Price Target: $78 → $74
Current: $72.28
Upside: +2.39%
ACADIA Pharmaceuticals
Sep 11, 2025
Maintains: Buy
Price Target: $35 → $39
Current: $27.27
Upside: +43.01%
Madrigal Pharmaceuticals
Aug 26, 2025
Maintains: Buy
Price Target: $390 → $554
Current: $561.44
Upside: -1.33%
Spero Therapeutics
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.60
Upside: -
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.10
Upside: -
Oct 21, 2024
Maintains: Buy
Price Target: $282 → $371
Current: $421.74
Upside: -12.03%
Aug 8, 2023
Initiates: Outperform
Price Target: n/a
Current: $5.55
Upside: -
Mar 22, 2023
Maintains: Outperform
Price Target: $125 → $175
Current: $22.60
Upside: +674.34%
Nov 23, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $82.01
Upside: -
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.70
Upside: -
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $17.15
Upside: -
Jul 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.97
Upside: -
Mar 2, 2021
Initiates: Outperform
Price Target: n/a
Current: $38.53
Upside: -
Jun 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.33
Upside: -
Jul 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $0.55
Upside: -
Jan 12, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $619.43
Upside: -